Mitochondrial hepatopathies in the newborn period

Seminars in Fetal and Neonatal Medicine

Volumn 16, Issue 4, 2011, Pages 222-228

  Fellman, Vineta ^a,b   Kotarsky, Heike ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Assembly factors; Fatty liver disease; GRACILE syndrome; Liver failure; Newborn infant; Oxidative phosphorylation defect

Indexed keywords

AMINOTRANSFERASE; CARNITINE; CELL NUCLEUS DNA; CYTOCHROME C OXIDASE; DEOXYGUANOSINE KINASE; GLYCOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINYL COENZYME A SYNTHETASE; TRANSFER RNA; UBIQUINOL CYTOCHROME C REDUCTASE;

AMINOTRANSFERASE BLOOD LEVEL; C10ORF2 GENE; CARDIOMYOPATHY; CHOLESTASIS; CLINICAL FEATURE; CYTOCHROME C OXIDASE DEFICIENCY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA REPAIR; DNA TRANSCRIPTION; EFG1 GENE; EFTU GENE; ENZYME ACTIVITY; FATTY ACID OXIDATION; FATTY LIVER; FOLLOW UP; GENE; GENE MUTATION; GENETIC CODE; HEPATOMEGALY; HUMAN; HYPOGLYCEMIA; LACTIC ACIDOSIS; LIPID STORAGE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER TRANSPLANTATION; LOW CARBOHYDRATE DIET; METABOLIC DISORDER; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL DNA DEPLETION SYNDROME; MITOCHONDRIAL DNA REPLICATION; MPV17 GENE; MUSCLE BIOPSY; NEUROLOGIC DISEASE; NEWBORN DEATH; NEWBORN DISEASE; NEWBORN MORTALITY; POLG1 GENE; PROTEIN EXPRESSION; RESPIRATORY CHAIN, OXIDATIVE PHOSPHORYLATION AND CELLULAR ENERGETICS; REVIEW; TRMU GENE;

ELECTRON TRANSPORT; HUMANS; INFANT, NEWBORN; LIVER DISEASES; MITOCHONDRIA, LIVER; MITOCHONDRIAL DISEASES;

EID: 79959869854     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2011.05.002     Document Type: Review

References (57)

1. Gibson K., Halliday J.L., Kirby D.M., Yaplito-Lee J., Thorburn D.R., Boneh A. Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnoses. Pediatrics 2008, 122:1003-1008.
2. Garcia-Cazorla A., De Lonlay P., Nassogne M.C., Rustin P., Touati G., Saudubray J.M. Long-term follow-up of neonatal mitochondrial cytopathies: a study of 57 patients. Pediatrics 2005, 116:1170-1177.
3. Garcia-Cazorla A., De Lonlay P., Rustin P., et al. Mitochondrial respiratory chain deficiencies expressing the enzymatic deficiency in the hepatic tissue: a study of 31 patients. J Pediatr 2006, 149:401-405.
4. Pessayre D. Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2007, 22(Suppl. 1):S20-S27.
5. Lee W.S., Sokol R.J. Mitochondrial hepatopathies: advances in genetics and pathogenesis. Hepatology 2007, 45:1555-1565.
6. Pagliarini D.J., Calvo S.E., Chang B., et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123.
7. Haas R.H., Parikh S., Falk M.J., et al. The in-depth evaluation of suspected mitochondrial disease. Molec Genet Metab 2008, 94:16-37.
8. Wong L.J., Scaglia F., Graham B.H., Craigen W.J. Current molecular diagnostic algorithm for mitochondrial disorders. Mol Genet Metab 2010, 100:111-117.
9. Spiekerkoetter U. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening. J Inherit Metab Dis 2010, 33:527-532.
10. Summar M.L., Dobbelaere D., Brusilow S., Lee B. Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr 2008, 97:1420-1425.
11. Begriche K., Massart J., Robin M.A., Borgne-Sanchez A., Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 2011, 54:773-794.
12. Fragaki K., Procaccio V., Bannwarth S., et al. A neonatal polyvisceral failure linked to a de novo homoplasmic mutation in the mitochondrially encoded cytochrome b gene. Mitochondrion 2009, 9:346-352.
13. Horvath R., Kemp J.P., Tuppen H.A., et al. Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy. Brain 2009, 132:3165-3174.
14. Gibson K.M., Bennett M.J., Mize C.E., et al. 3-Methylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects. J Pediatr 1992, 121:940-942.
15. Dimmock D., Tang L.Y., Schmitt E.S., Wong L.J. Quantitative evaluation of the mitochondrial DNA depletion syndrome. Clin Chem 2010, 56:1119-1127.
16. Chi C.S., Lee H.F., Tsai C.R., Lee H.J., Chen L.H. Clinical manifestations in children with mitochondrial diseases. Pediatr Neurol 2010, 43:183-189.
17. Mandel H., Szargel R., Labay V., et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001, 29:337-341.
18. Labarthe F., Dobbelaere D., Devisme L., et al. Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency. J Hepatol 2005, 43:333-341.
19. Pronicka E., Weglewska-Jurkiewicz A., Taybert J., et al. Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure. J Appl Genet 2011, 52:61-66.
20. Spinazzola A., Viscomi C., Fernandez-Vizarra E., et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006, 38:570-575.
21. Wong L.J., Brunetti-Pierri N., Zhang Q., et al. Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology 2007, 46:1218-1227.
22. Van Hove J.L., Saenz M.S., Thomas J.A., et al. Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy. Pediatr Res 2010, 68:159-164.
23. Wong L.J., Naviaux R.K., Brunetti-Pierri N., et al. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 2008, 29:E150-E172.
24. Sarzi E., Goffart S., Serre V., et al. Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol 2007, 62:579-587.
25. Hakonen A.H., Isohanni P., Paetau A., Herva R., Suomalainen A., Lonnqvist T. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 2007, 130:3032-3040.
26. Hanson P.I., Whiteheart S.W. AAA+ proteins: have engine, will work. Nat Rev Mol Cell Biol 2005, 6:519-529.
27. Nobrega F.G., Nobrega M.P., Tzagoloff A. BCS1, a novel gene required for the expression of functional Rieske iron-sulfur protein in Saccharomyces cerevisiae. EMBO J 1992, 11:3821-3829.
28. Nouet C., Truan G., Mathieu L., Dujardin G. Functional analysis of yeast bcs1 mutants highlights the role of Bcs1p-specific amino acids in the AAA domain. J Molec Biol 2009, 388:252-261.
29. Guzy R.D., Hoyos B., Robin E., et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 2005, 1:401-408.
30. de Lonlay P., Valnot I., Barrientos A., et al. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 2001, 29:57-60.
31. Visapaa I., Fellman V., Vesa J., et al. GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 2002, 71:863-876.
32. De Meirleir L., Seneca S., Damis E., et al. Clinical and diagnostic characteristics of complex III deficiency due to mutations in the BCS1L gene. Am J Med Genet A 2003, 121:126-131.
33. Fernandez-Vizarra E., Bugiani M., Goffrini P., et al. Impaired complex III assembly associated with BCS1L gene mutations in isolated mitochondrial encephalopathy. Hum Molec Genet 2007, 16:1241-1252.
34. Hinson J.T., Fantin V.R., Schonberger J., et al. Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome. N Engl J Med 2007, 356:809-819.
35. Blazquez A., Gil-Borlado M.C., Moran M., et al. Infantile mitochondrial encephalomyopathy with unusual phenotype caused by a novel BCS1L mutation in an isolated complex III-deficient patient. Neuromuscul Disord 2009, 19:143-146.
36. Gil-Borlado M.C., Gonzalez-Hoyuela M., Blazquez A., et al. Pathogenic mutations in the 5′ untranslated region of BCS1L mRNA in mitochondrial complex III deficiency. Mitochondrion 2009, 9:299-305.
37. Fernandez-Vizarra E., Tiranti V., Zeviani M. Assembly of the oxidative phosphorylation system in humans: what we have learned by studying its defects. Biochim Biophys Acta 2009, 1793:200-211.
38. Ramos-Arroyo M.A., Hualde J., Ayechu A., et al. Clinical and biochemical spectrum of mitochondrial complex III deficiency caused by mutations in the BCS1L gene. Clin Genet 2009, 75:585-587.
39. Tuppen H.A., Fehmi J., Czermin B., et al. Long-term survival of neonatal mitochondrial complex III deficiency associated with a novel BCS1L gene mutation. Molec Genet Metab 2010, 100:345-348.
40. Fellman V., Rapola J., Pihko H., Varilo T., Raivio K.O. Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduria. Lancet 1998, 351:490-493.
41. Fellman V., Lemmela S., Sajantila A., Pihko H., Jarvela I. Screening of BCS1L mutations in severe neonatal disorders suspicious for mitochondrial cause. J Hum Genet 2008, 53:554-558.
42. Fellman V., Visapaa I., Vujic M., Wennerholm U.B., Peltonen L. Antenatal diagnosis of hereditary fetal growth retardation with aminoaciduria, cholestasis, iron overload, and lactic acidosis in the newborn infant. Acta Obstet Gynecol Scand 2002, 81:398-402.
43. Rapola J., Heikkila P., Fellman V. Pathology of lethal fetal growth retardation syndrome with aminoaciduria, iron overload, and lactic acidosis (GRACILE). Pediatr Pathol Mol Med 2002, 21:183-193.
44. Fellman V. The GRACILE syndrome, a neonatal lethal metabolic disorder with iron overload. Blood Cells Mol Dis 2002, 29:444-450.
45. Kotarsky H., Karikoski R., Mörgelin M., et al. Characterization of complex III deficiency and liver dysfunction in GRACILE syndrome caused by a BCS1L mutation. Mitochondrion 2010, 10:497-509.
46. Moran M., Marin-Buera L., Gil-Borlado M.C., et al. Cellular pathophysiological consequences of BCS1L mutations in mitochondrial complex III enzyme deficiency. Hum Mutat 2010, 31:930-941.
47. Rahman S., Hargreaves I., Clayton P., Heales S. Neonatal presentation of coenzyme Q10 deficiency. J Pediatr 2001, 139:456-458.
48. Gil Borlado M.C., Moreno Lastres D., Gonzalez Hoyuela M., et al. Impact of the mitochondrial genetic background in complex III deficiency. PLoS One 2010, 5:e12801.
49. Barel O., Shorer Z., Flusser H., et al. Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ. Am J Hum Genet 2008, 82:1211-1216.
50. Levéen P., Kotarsky H., Mörgelin M., Karikoski R., Elmér E., Fellman V. The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency; a viable mouse model for mitochondrial hepatopathy. Hepatology 2011, 53:437-447.
51. Valnot I., Osmond S., Gigarel N., et al. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 2000, 67:1104-1109.
52. Zeharia A., Shaag A., Pappo O., et al. Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet 2009, 85:401-407.
53. Kemp J.P., Smith P.M., Pyle A., et al. Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency. Brain 2011, 134:183-195.
54. Coenen M.J., Antonicka H., Ugalde C., et al. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med 2004, 351:2080-2086.
55. Smits P., Antonicka H., van Hasselt P.M., et al. Mutation in subdomain G′ of mitochondrial elongation factor G1 is associated with combined OXPHOS deficiency in fibroblasts but not in muscle. Eur J Hum Genet 2011, 19:275-279.
56. Valente L., Tiranti V., Marsano R.M., et al. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am J Hum Genet 2007, 80:44-58.
57. Haas R.H., Parikh S., Falk M.J., et al. Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 2007, 120:1326-1333.